174 related articles for article (PubMed ID: 23582560)
1. [Breast cancer during pregnancy and chemotherapy: a systematic review].
Monteiro DL; Trajano AJ; Menezes DC; Silveira NL; Magalhães AC; Miranda FR; Caldas B
Rev Assoc Med Bras (1992); 2013; 59(2):174-80. PubMed ID: 23582560
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Trastuzumab administration during pregnancy: an update.
Andrikopoulou A; Apostolidou K; Chatzinikolaou S; Bletsa G; Zografos E; Dimopoulos MA; Zagouri F
BMC Cancer; 2021 Apr; 21(1):463. PubMed ID: 33902516
[TBL] [Abstract][Full Text] [Related]
4. Emerging therapeutic options for breast cancer chemotherapy during pregnancy.
Mir O; Berveiller P; Ropert S; Goffinet F; Pons G; Treluyer JM; Goldwasser F
Ann Oncol; 2008 Apr; 19(4):607-13. PubMed ID: 17921242
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy with taxanes in breast cancer during pregnancy: case report and review of the literature.
Potluri V; Lewis D; Burton GV
Clin Breast Cancer; 2006 Jun; 7(2):167-70. PubMed ID: 16800979
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy for breast cancer during pregnancy: an 18-year experience from five London teaching hospitals.
Ring AE; Smith IE; Jones A; Shannon C; Galani E; Ellis PA
J Clin Oncol; 2005 Jun; 23(18):4192-7. PubMed ID: 15961766
[TBL] [Abstract][Full Text] [Related]
7. Trastuzumab use for metastatic breast cancer in pregnancy.
Sekar R; Stone PR
Obstet Gynecol; 2007 Aug; 110(2 Pt 2):507-10. PubMed ID: 17666645
[TBL] [Abstract][Full Text] [Related]
8. Management of breast cancer during pregnancy using a standardized protocol.
Berry DL; Theriault RL; Holmes FA; Parisi VM; Booser DJ; Singletary SE; Buzdar AU; Hortobagyi GN
J Clin Oncol; 1999 Mar; 17(3):855-61. PubMed ID: 10071276
[TBL] [Abstract][Full Text] [Related]
9. Five-year results of a phase II trial of preoperative 5-fluorouracil, epirubicin, cyclophosphamide followed by docetaxel with capecitabine (wTX) (with trastuzumab in HER2-positive patients) for patients with stage II or III breast cancer.
Holmes FA; Hellerstedt BA; Pippen JE; Vukelja SJ; Collea RP; Kocs DM; Blum JL; McIntyre KJ; Barve MA; Brooks BD; Osborne CR; Wang Y; Asmar L; O'Shaughnessy J
Cancer Med; 2018 Jun; 7(6):2288-2298. PubMed ID: 29582557
[TBL] [Abstract][Full Text] [Related]
10. Anhydramnios associated with administration of trastuzumab and paclitaxel for metastatic breast cancer during pregnancy.
Bader AA; Schlembach D; Tamussino KF; Pristauz G; Petru E
Lancet Oncol; 2007 Jan; 8(1):79-81. PubMed ID: 17196514
[No Abstract] [Full Text] [Related]
11. Maternal and fetal outcomes of taxane chemotherapy in breast and ovarian cancer during pregnancy: case series and review of the literature.
Cardonick E; Bhat A; Gilmandyar D; Somer R
Ann Oncol; 2012 Dec; 23(12):3016-3023. PubMed ID: 22875836
[TBL] [Abstract][Full Text] [Related]
12. Combined chemotherapy and radiotherapy during conception and first two trimesters of gestation in a woman with metastatic breast cancer.
Andreadis C; Charalampidou M; Diamantopoulos N; Chouchos N; Mouratidou D
Gynecol Oncol; 2004 Oct; 95(1):252-5. PubMed ID: 15385141
[TBL] [Abstract][Full Text] [Related]
13. Docetaxel administered during pregnancy for inflammatory breast carcinoma.
Nieto Y; Santisteban M; Aramendía JM; Fernández-Hidalgo O; García-Manero M; López G
Clin Breast Cancer; 2006 Feb; 6(6):533-4. PubMed ID: 16595038
[TBL] [Abstract][Full Text] [Related]
14. Use of pertuzumab and trastuzumab during pregnancy.
Yildirim N; Bahceci A
Anticancer Drugs; 2018 Sep; 29(8):810-813. PubMed ID: 30110018
[TBL] [Abstract][Full Text] [Related]
15. Neonatal effects of breast cancer chemotherapy administered during pregnancy.
Kerr JR
Pharmacotherapy; 2005 Mar; 25(3):438-41. PubMed ID: 15843292
[TBL] [Abstract][Full Text] [Related]
16. Breast cancer and pregnancy: how safe is trastuzumab?
Azim HA; Peccatori FA; Liptrott SJ; Catania C; Goldhirsch A
Nat Rev Clin Oncol; 2009 Jun; 6(6):367-70. PubMed ID: 19483741
[TBL] [Abstract][Full Text] [Related]
17. Treatment of pregnant breast cancer patients and outcomes of children exposed to chemotherapy in utero.
Hahn KM; Johnson PH; Gordon N; Kuerer H; Middleton L; Ramirez M; Yang W; Perkins G; Hortobagyi GN; Theriault RL
Cancer; 2006 Sep; 107(6):1219-26. PubMed ID: 16894524
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of children exposed in utero to chemotherapy for breast cancer.
Murthy RK; Theriault RL; Barnett CM; Hodge S; Ramirez MM; Milbourne A; Rimes SA; Hortobagyi GN; Valero V; Litton JK
Breast Cancer Res; 2014 Dec; 16(6):500. PubMed ID: 25547133
[TBL] [Abstract][Full Text] [Related]
19. In utero exposure to breast cancer treatment: a population-based perinatal outcome study.
Safi N; Anazodo A; Dickinson JE; Lui K; Wang AY; Li Z; Sullivan EA
Br J Cancer; 2019 Oct; 121(8):719-721. PubMed ID: 31488880
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy in pregnancy.
Brewer M; Kueck A; Runowicz CD
Clin Obstet Gynecol; 2011 Dec; 54(4):602-18. PubMed ID: 22031250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
